User Visitor Login
/images/graph_sv_i.gif
English only
EPFL > FSV > BBP > Channelpedia
Ion channels
References
Reports
SEARCH IN WIKI
Logged in as a Visitor.

All references automaticaly matched for Cav1.1


260. Pubmed Liu Y. et al. Unique Expression of Angiotensin Type-2 Receptor in Sex-Specific Distribution of Myelinated Ah-Type Baroreceptor Neuron Contributing to Sex-Dimorphic Neurocontrol of Circulation. Hypertension, 2016 Feb 16 , ().
259. Pubmed Kim H. et al. Protein Network Interacting with BK Channels. Int. Rev. Neurobiol., 2016 , 128 (127-61).
258. Pubmed Georgiou D. et al. Ca2+ Binding/Permeation via Calcium Channel, CaV1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism. J. Biol. Chem., 2015 Sep 25 , 290 (23751-65).
257. Pubmed Zhang Y. et al. KCa1.1 is potential marker for distinguishing Ah-type baroreceptor neurons in NTS and contributes to sex-specific presynaptic neurotransmission in baroreflex afferent pathway. Neurosci. Lett., 2015 Sep 14 , 604 (1-6).
256. Pubmed Golder F. et al. Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator. Anesthesiology, 2015 Nov , 123 (1093-104).
255. Pubmed Yu L. et al. Unoprostone activation of BK (KCa1.1) channel splice variants. Biochim. Biophys. Acta, 2015 Nov , 1848 (2859-67).
254. Pubmed Fiszer D. et al. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness. Anesthesiology, 2015 May , 122 (1033-46).
253. Pubmed Benedetti B. et al. Physiological and pharmacological modulation of the embryonic skeletal muscle calcium channel splice variant CaV1.1e. Biophys. J., 2015 Mar 10 , 108 (1072-80).
252. Pubmed Gillies R. et al. Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families. Anaesth Intensive Care, 2015 Mar , 43 (157-66).
251. Pubmed Dominguez Rieg J. et al. P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37. Acta Physiol (Oxf), 2015 Mar , 213 (628-41).
250. Pubmed Ma Y. et al. Epoxyeicosatrienoic acids act through TRPV4-TRPC1-KCa1.1 complex to induce smooth muscle membrane hyperpolarization and relaxation in human internal mammary arteries. Biochim. Biophys. Acta, 2015 Mar , 1852 (552-9).
249. Pubmed Jia B. et al. Muscle edema of the lower limb determined by MRI in Asian hypokalaemic periodic paralysis patients. Neurol. Res., 2015 Mar , 37 (246-52).
248. Pubmed Grajales L. et al. Temporal expression of calcium channel subunits in satellite cells and bone marrow mesenchymal cells. Stem Cell Rev, 2015 Jun , 11 (408-22).
247. Pubmed Xu W. et al. KCa1.1 β4-subunits are not responsible for iberiotoxin-resistance in baroreceptor neurons in adult male rats. Int. J. Cardiol., 2015 Jan 15 , 178 (184-7).
246. Pubmed Polster A. et al. Stac adaptor proteins regulate trafficking and function of muscle and neuronal L-type Ca2+ channels. Proc. Natl. Acad. Sci. U.S.A., 2015 Jan 13 , 112 (602-6).
245. Pubmed Tanner M. et al. KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis. , 2015 Jan , 67 (96-106).
244. Pubmed Lopez R. et al. Raptor ablation in skeletal muscle decreases Cav1.1 expression and affects the function of the excitation-contraction coupling supramolecular complex. Biochem. J., 2015 Feb 15 , 466 (123-35).
243. Pubmed Oliván-Viguera A. et al. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo. Mol. Pharmacol., 2015 Feb , 87 (338-48).
242. Pubmed Turner R. et al. Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system. Pflugers Arch., 2015 Feb , 467 (311-28).
241. Pubmed Wu J. et al. Structure of the voltage-gated calcium channel Cav1.1 complex. Science, 2015 Dec 18 , 350 (aad2395).
240. Pubmed Liu Y. et al. KCa1.1-mediated frequency-dependent central and peripheral neuromodulation via Ah-type baroreceptor neurons located within nodose ganglia and nucleus of solitary tract of female rats. Int. J. Cardiol., 2015 Apr 15 , 185 (84-7).
239. Pubmed Berthier C. et al. Depression of voltage-activated Ca2+ release in skeletal muscle by activation of a voltage-sensing phosphatase. J. Gen. Physiol., 2015 Apr , 145 (315-30).
238. Pubmed Cannon S. et al. Channelopathies of skeletal muscle excitability. Compr Physiol, 2015 Apr , 5 (761-90).
237. Pubmed Ohrtman J. et al. Apparent lack of physical or functional interaction between CaV1.1 and its distal C terminus. J. Gen. Physiol., 2015 Apr , 145 (303-14).
236. Pubmed Parajuli S. et al. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells. Pflugers Arch., 2015 Apr , 467 (665-75).
235. Pubmed Subramanian M. et al. Idiopathic generalized epilepsy and hypokalemic periodic paralysis in a family of South Indian descent. Case Rep Neurol Med, 2015 , 2015 (906049).
234. Pubmed Hernãndez-Ochoa E. et al. Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease. Front Physiol, 2015 , 6 (420).
233. Pubmed Antony C. et al. Regulation of L-type Voltage Gated Calcium Channel CACNA1S in Macrophages upon Mycobacterium tuberculosis Infection. PLoS ONE, 2015 , 10 (e0124263).
232. Pubmed Liu X. et al. Mutations of SCN4A gene cause different diseases: 2 case reports and literature review. Channels (Austin), 2015 , 9 (82-7).
231. Pubmed Rabjerg M. et al. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival. PLoS ONE, 2015 , 10 (e0122992).
230. Pubmed Mahalingam M. et al. Structural mapping of divergent regions in the type 1 ryanodine receptor using fluorescence resonance energy transfer. Structure, 2014 Sep 2 , 22 (1322-32).
229. Pubmed Petkov G. et al. Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2014 Sep 15 , 307 (R571-84).
228. Pubmed Bartok A. et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels. Toxicon, 2014 Sep , 87 (6-16).
227. Pubmed Stunnenberg B. et al. Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause? Muscle Nerve, 2014 Sep , 50 (327-32).
226. Pubmed Nausch B. et al. NS19504: a novel BK channel activator with relaxing effect on bladder smooth muscle spontaneous phasic contractions. J. Pharmacol. Exp. Ther., 2014 Sep , 350 (520-30).
225. Pubmed Zhang P. et al. Nitric oxide and protein kinase G act on TRPC1 to inhibit 11,12-EET-induced vascular relaxation. Cardiovasc. Res., 2014 Oct 1 , 104 (138-46).
224. Pubmed Ge L. et al. Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. Int. Immunopharmacol., 2014 Oct , 22 (427-43).
223. Pubmed Beqollari D. et al. Differential effects of RGK proteins on L-type channel function in adult mouse skeletal muscle. Biophys. J., 2014 May 6 , 106 (1950-7).
222. Pubmed Climent B. et al. Effects of obesity on vascular potassium channels. Curr Vasc Pharmacol, 2014 May , 12 (438-52).
221. Pubmed Toro L. et al. MaxiK channel and cell signalling. Pflugers Arch., 2014 May , 466 (875-86).
220. Pubmed Na S. et al. Whole-genome analysis in Korean patients with autoimmune myasthenia gravis. Yonsei Med. J., 2014 May , 55 (660-8).
219. Pubmed Chaube R. et al. Regulation of the skeletal muscle ryanodine receptor/Ca2+-release channel RyR1 by S-palmitoylation. J. Biol. Chem., 2014 Mar 21 , 289 (8612-9).
218. Pubmed Tummala S. et al. Localization of Cacna1s to ON bipolar dendritic tips requires mGluR6-related cascade elements. Invest. Ophthalmol. Vis. Sci., 2014 Mar , 55 (1483-92).
217. Pubmed Fuller M. et al. Differential regulation of CaV1.2 channels by cAMP-dependent protein kinase bound to A-kinase anchoring proteins 15 and 79/150. J. Gen. Physiol., 2014 Mar , 143 (315-24).
216. Pubmed Taylor J. et al. The Cavβ1a subunit regulates gene expression and suppresses myogenin in muscle progenitor cells. J. Cell Biol., 2014 Jun 23 , 205 (829-46).
215. Pubmed Wu C. et al. Disease and region-related cardiac fibroblast potassium current variations and potential functional significance. Cardiovasc. Res., 2014 Jun 1 , 102 (487-96).
214. Pubmed Li H. et al. Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel. Eur. J. Pharmacol., 2014 Jul 15 , 735 (38-43).
213. Pubmed Ruchala I. et al. Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels. Cell Calcium, 2014 Jul , 56 (25-33).
212. Pubmed Turner R. et al. T-type channels buddy up. Pflugers Arch., 2014 Jan 11 , ().
211. Pubmed Hernãndez-Ochoa E. et al. β1a490-508, a 19-residue peptide from C-terminal tail of Cav1.1 β1a subunit, potentiates voltage-dependent calcium release in adult skeletal muscle fibers. Biophys. J., 2014 Feb 4 , 106 (535-47).
210. Pubmed Sheng J. et al. Electrophysiology of human cardiac atrial and ventricular telocytes. J. Cell. Mol. Med., 2014 Feb , 18 (355-62).
209. Pubmed Stowell K. et al. DNA testing for malignant hyperthermia: the reality and the dream. Anesth. Analg., 2014 Feb , 118 (397-406).
208. Pubmed Wang Y. et al. [Ca(2+)-activated K(+) channel switching in smooth muscle participates in atherosclerosis development in diabetic rats]. Nan Fang Yi Ke Da Xue Xue Bao, 2014 Feb , 34 (188-92).
207. Pubmed Larach M. et al. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesth. Analg., 2014 Dec , 119 (1359-66).
206. Pubmed Sánchez-Pastor E. et al. Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit. Eur. J. Pharmacol., 2014 Apr 15 , 729 (100-6).
205. Pubmed Robert V. et al. Protein kinase C-dependent activation of CaV1.2 channels selectively controls human TH2-lymphocyte functions. J. Allergy Clin. Immunol., 2014 Apr , 133 (1175-83).
204. Pubmed Kunert-Keil C. et al. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice. J. Physiol. Pharmacol., 2014 Apr , 65 (317-24).
203. Pubmed Takacs Z. et al. Interaction of the BKCa channel gating ring with dendrotoxins. Channels (Austin), 2014 , 8 (421-32).
202. Pubmed Zapata M. et al. Molecular cloning of ion channels in Felis catus that are related to periodic paralyses in man: a contribution to the understanding of the genetic susceptibility to feline neck ventroflexion and paralysis. Biol Open, 2014 , 3 (785-93).
201. Pubmed Yang B. et al. A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy. BMC Urol, 2014 , 14 (96).
200. Pubmed Lau K. et al. Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. Nat Commun, 2014 , 5 (5397).
199. Pubmed Watanabe A. et al. In silico identification of the genes for sperm-egg interaction in the internal fertilization of the newt Cynops pyrrhogaster. Int. J. Dev. Biol., 2014 , 58 (873-9).
198. Pubmed Guerrero-Hernández A. et al. Ryanodine receptors as leak channels. Eur. J. Pharmacol., 2013 Nov 28 , ().
197. Pubmed Gonsalves S. et al. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology, 2013 Nov , 119 (1043-53).
196. Pubmed Kim J. et al. Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families. Anesthesiology, 2013 Nov , 119 (1054-65).
195. Pubmed Yu Z. et al. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation. Pharmacol. Res., 2013 Nov , 77 (30-8).
194. Pubmed Bannister R. et al. Impaired gating of an L-Type Ca(2+) channel carrying a mutation linked to malignant hyperthermia. Biophys. J., 2013 May 7 , 104 (1917-22).
193. Pubmed Stoneking C. et al. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells. Am. J. Physiol., Cell Physiol., 2013 May 1 , 304 (C858-72).
192. Pubmed Campiglio M. et al. Stable incorporation versus dynamic exchange of β subunits in a native Ca2+ channel complex. J. Cell. Sci., 2013 May 1 , 126 (2092-101).
191. Pubmed Brandom B. et al. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States. Anesth. Analg., 2013 May , 116 (1078-86).
190. Pubmed Hanchard N. et al. Exploring the utility of whole-exome sequencing as a diagnostic tool in a child with atypical episodic muscle weakness. Clin. Genet., 2013 May , 83 (457-61).
189. Pubmed Jorquera G. et al. Cav1.1 controls frequency-dependent events regulating adult skeletal muscle plasticity. J. Cell. Sci., 2013 Mar 1 , 126 (1189-98).
188. Pubmed Eltit J. et al. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia. FASEB J., 2013 Mar , 27 (991-1000).
187. Pubmed Takai J. et al. Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+/calmodulin-dependent protein kinase kinase/Akt/p300 cascade. Am. J. Physiol. Heart Circ. Physiol., 2013 Jun 21 , ().
186. Pubmed Park W. et al. Functional expression of smooth muscle-specific ion channels in TGF-β1-treated human adipose-derived mesenchymal stem cells. Am. J. Physiol., Cell Physiol., 2013 Jun 12 , ().
185. Pubmed Engbers J. et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels. Channels (Austin), 2013 Jul 31 , 7 ().
184. Pubmed Zhang Y. et al. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells. J. Cell. Physiol., 2013 Jul 23 , ().
183. Pubmed Nam T. et al. An algorithm for candidate sequencing in non-dystrophic skeletal muscle channelopathies. J. Neurol., 2013 Jul , 260 (1770-7).
182. Pubmed Suzuki Y. et al. Direct molecular interaction of caveolin-3 with KCa1.1 channel in living HEK293 cell expression system. Biochem. Biophys. Res. Commun., 2013 Jan 18 , 430 (1169-74).
181. Pubmed Ke Q. et al. Gender differences in penetrance and phenotype in hypokalemic periodic paralysis. Muscle Nerve, 2013 Jan , 47 (41-5).
180. Pubmed Schiemann A. et al. Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia. Br J Anaesth, 2013 Jan , 110 (122-7).
179. Pubmed Wei C. et al. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis]. Zhonghua Er Ke Za Zhi, 2013 Jan , 51 (47-51).
178. Pubmed Fritsch E. et al. Triclosan impairs swimming behavior and alters expression of excitation-contraction coupling proteins in fathead minnow (Pimephales promelas). Environ. Sci. Technol., 2013 Feb 19 , 47 (2008-17).
177. Pubmed Yang Y. et al. Function of BKCa channels is reduced in human vascular smooth muscle cells from Han Chinese patients with hypertension. Hypertension, 2013 Feb , 61 (519-25).
176. Pubmed Wu F. et al. Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis. Brain, 2013 Dec , 136 (3766-74).
175. Pubmed Novaković R. et al. The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K(+) channels. J. Physiol. Pharmacol., 2013 Dec , 64 (795-805).
174. Pubmed Lefebvre R. et al. Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants. PLoS ONE, 2013 , 8 (e54042).
173. Pubmed Oliván-Viguera A. et al. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3. PLoS ONE, 2013 , 8 (e58614).
172. Pubmed Wu W. et al. Cholesterol down-regulates BK channels stably expressed in HEK 293 cells. PLoS ONE, 2013 , 8 (e79952).
171. Pubmed Rehak R. et al. Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes. PLoS ONE, 2013 , 8 (e61844).
170. Pubmed Taiakina V. et al. The calmodulin-binding, short linear motif, NSCaTE is conserved in L-type channel ancestors of vertebrate Cav1.2 and Cav1.3 channels. PLoS ONE, 2013 , 8 (e61765).
169. Pubmed Lee E. et al. Transthyretin is a key regulator of myoblast differentiation. PLoS ONE, 2013 , 8 (e63627).
168. Pubmed Valladares D. et al. Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy. PLoS ONE, 2013 , 8 (e75340).
167. Pubmed Xin W. et al. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel. Am. J. Physiol. Renal Physiol., 2012 Nov 1 , 303 (F1300-6).
166. Pubmed Hu X. et al. KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis. J. Biol. Chem., 2012 Feb 3 , 287 (4014-22).
165. Pubmed Zhang J. et al. Regulation of Cell Proliferation of Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells via Ether a go-go 1 (hEAG1) Potassium Channel. , 2012 Feb 22 , ().
164. Pubmed Parker M. et al. HCO3--independent conductance with a mutant Na/HCO3 cotransporter (SLC4A4) in a case of proximal renal tubular acidosis with hypokalemic paralysis. , 2012 Feb 13 , ().
163. Pubmed Li F. et al. A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance. J. Mol. Neurosci., 2012 Feb , 46 (378-83).
162. Pubmed George A. et al. Leaky channels make weak muscles. J. Clin. Invest., 2012 Dec 3 , 122 (4333-6).
161. Pubmed Wu F. et al. A calcium channel mutant mouse model of hypokalemic periodic paralysis. J. Clin. Invest., 2012 Dec 3 , 122 (4580-91).
160. Pubmed Schild J. et al. Differential distribution of voltage-gated channels in myelinated and unmyelinated baroreceptor afferents. Auton Neurosci, 2012 Dec 24 , 172 (4-12).
159. Pubmed Zhang J. et al. Role of the BK channel (KCa1.1) during activation of electrogenic K+ secretion in guinea pig distal colon. Am. J. Physiol. Gastrointest. Liver Physiol., 2012 Dec 15 , 303 (G1322-34).
158. Pubmed Horrigan F. et al. Perspectives on: Conformational coupling in ion channels: Conformational coupling in BK potassium channels. J. Gen. Physiol., 2012 Dec , 140 (625-34).
157. Pubmed Song Y. et al. Normokalemic periodic paralysis is not a distinct disease. Muscle Nerve, 2012 Dec , 46 (914-6).
156. Pubmed Yamamura H. et al. Molecular assembly and dynamics of fluorescent protein-tagged single KCa1.1 channel in expression system and vascular smooth muscle cells. Am. J. Physiol., Cell Physiol., 2012 Apr 15 , 302 (C1257-68).
155. Pubmed Sung C. et al. Genotype and phenotype analysis of patients with sporadic periodic paralysis. Am. J. Med. Sci., 2012 Apr , 343 (281-5).
154. Pubmed Evans A. et al. Ion Channel Regulation by the LKB1-AMPK Signalling Pathway: The Key to Carotid Body Activation by Hypoxia and Metabolic Homeostasis at the Whole Body Level. Adv. Exp. Med. Biol., 2012 , 758 (81-90).
153. Pubmed Krasnyĭ A. et al. [The expression of genes encoding the voltage-dependent L-type Ca2+ channels in proliferating and differentiating C2C12 myoblasts of mice]. Izv. Akad. Nauk. Ser. Biol., 2011 May-Jun , (349-53).
152. Pubmed Wu F. et al. A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis. J. Clin. Invest., 2011 Oct 3 , 121 (4082-94).
151. Pubmed Hirano M. et al. A novel mutation in the calcium channel gene in a family with hypokalemic periodic paralysis. J. Neurol. Sci., 2011 Oct 15 , 309 (9-11).
150. Pubmed Banas K. et al. The KATP channel Kir6.2 subunit content is higher in glycolytic than oxidative skeletal muscle fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011 Oct , 301 (R916-25).
149. Pubmed Burge J. et al. Novel Insights into the Pathomechanisms of Skeletal Muscle Channelopathies. , 2011 Nov 15 , ().
148. Pubmed Kim H. et al. Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations. Korean J Pediatr, 2011 Nov , 54 (473-6).
147. Pubmed Francis D. et al. Leaky sodium channels from voltage sensor mutations in periodic paralysis, but not paramyotonia. Neurology, 2011 May 10 , 76 (1635-41).
146. Pubmed Tammaro A. et al. Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families. Clin. Genet., 2011 May , 79 (438-47).
145. Pubmed Kraeva N. et al. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population. Can J Anaesth, 2011 Jun , 58 (504-13).
144. Pubmed Li B. et al. KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents. Am. J. Physiol., Cell Physiol., 2011 Jun , 300 (C1393-403).
143. Pubmed Xiao Z. et al. [The relationships between the single nueleotide polymorphisms of CACNA1S gene 11 exon and thyrotoxic hypokalemic periodic paralysis in the people of Han Nationality in Sichuan Province, China]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2011 Jun , 28 (547-52, 558).
142. Pubmed Delbono O. et al. Expression and regulation of excitation-contraction coupling proteins in aging skeletal muscle. Curr Aging Sci, 2011 Dec , 4 (248-59).
141. Pubmed He M. et al. Effects of ion channels on proliferation in cultured human cardiac fibroblasts. J. Mol. Cell. Cardiol., 2011 Aug , 51 (198-206).
140. Pubmed Kryshtal' D. et al. [Changes in calcium-dependent potassium channels of isolated smooth muscle cells of the bladder in rats with experimental diabetes]. Fiziol Zh, 2011 , 57 (25-32).
139. Pubmed Stroffekova K. et al. The IQ motif is crucial for Cav1.1 function. J. Biomed. Biotechnol., 2011 , 2011 (504649).
138. Pubmed Incecik F. et al. Hypokalemic periodic paralysis due to the SCN4A R672H mutation in a Turkish family. Turk. J. Pediatr., 2010 Jul-Aug , 52 (409-10).
137. Pubmed Raja Rayan D. et al. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr. Opin. Neurol., 2010 Oct , 23 (466-76).
136. Pubmed Kil T. et al. Severe respiratory phenotype caused by a de novo Arg528Gly mutation in the CACNA1S gene in a patient with hypokalemic periodic paralysis. Eur. J. Paediatr. Neurol., 2010 May , 14 (278-81).
135. Pubmed Sorensen M. et al. Adrenaline-induced colonic K+ secretion is mediated via KCa1.1 (BK) channel. , 2010 Mar 29 , ().
134. Pubmed Zhou H. et al. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul. Disord., 2010 Mar , 20 (166-73).
133. Pubmed Li J. et al. Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channel. J Musculoskelet Neuronal Interact, 2010 Jun , 10 (180-7).
132. Pubmed Toppin P. et al. A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene. Can J Anaesth, 2010 Jul , 57 (689-93).
131. Pubmed Cannon S. et al. Voltage-Sensor Mutations in Channelopathies of Skeletal Muscle. , 2010 Feb 15 , ().
130. Pubmed Sorensen M. et al. Colonic potassium handling. , 2010 Feb 10 , ().
129. Pubmed Matthews E. et al. Muscle channelopathies: does the predicted channel gating pore offer new treatment options for hypokalaemic periodic paralysis? , 2010 Feb 1 , ().
128. Pubmed Pirone A. et al. Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit. Am. J. Physiol., Cell Physiol., 2010 Dec , 299 (C1345-54).
127. Pubmed Schicker K. et al. P2Y1 receptors mediate an activation of neuronal calcium-dependent K+ channels. , 2010 Aug 2 , ().
126. Pubmed Chiu Y. et al. Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-activated potassium channel splice variant. Mol. Pharmacol., 2010 Apr , 77 (497-507).
125. Pubmed Xu X. et al. Long-term fish oil supplementation induces cardiac electrical remodeling by changing channel protein expression in the rabbit model. PLoS ONE, 2010 , 5 (e10140).
124. Pubmed Sones W. et al. Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels. Br. J. Pharmacol., 2009 Sep , 158 (521-31).
123. Pubmed Taylor J. et al. Increased CaVbeta1A expression with aging contributes to skeletal muscle weakness. Aging Cell, 2009 Sep , 8 (584-94).
122. Pubmed Bentzen B. et al. Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo. , 2009 Oct 2 , ().
121. Pubmed Ke T. et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family. J. Hum. Genet., 2009 Nov , 54 (660-4).
120. Pubmed Matthews E. et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology, 2009 May 5 , 72 (1544-7).
119. Pubmed Harron S. et al. Volume regulation in the human airway epithelial cell line Calu-3. Can. J. Physiol. Pharmacol., 2009 May , 87 (337-46).
118. Pubmed Jurkat-Rott K. et al. K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. Proc. Natl. Acad. Sci. U.S.A., 2009 Mar 10 , 106 (4036-41).
117. Pubmed Kaufmann W. et al. Large-conductance calcium-activated potassium channels in purkinje cell plasma membranes are clustered at sites of hypolemmal microdomains. J. Comp. Neurol., 2009 Jul 10 , 515 (215-30).
116. Pubmed Maffè S. et al. Atypical arrhythmic complications in familial hypokalemic periodic paralysis. J Cardiovasc Med (Hagerstown), 2009 Jan , 10 (68-71).
115. Pubmed Tuluc P. et al. A CaV1.1 Ca2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle. Biophys. J., 2009 Jan , 96 (35-44).
114. Pubmed Hu H. et al. Characterization of ion channels in human preadipocytes. J. Cell. Physiol., 2009 Feb , 218 (427-35).
113. Pubmed Specht D. et al. Effects of presynaptic mutations on a postsynaptic Cacna1s calcium channel colocalized with mGluR6 at mouse photoreceptor ribbon synapses. Invest. Ophthalmol. Vis. Sci., 2009 Feb , 50 (505-15).
112. Pubmed Poulsen A. et al. Differential expression of BK channel isoforms and beta-subunits in rat neuro-vascular tissues. Biochim. Biophys. Acta, 2009 Feb , 1788 (380-9).
111. Pubmed Köhler R. et al. Single-nucleotide polymorphisms in vascular Ca(2+)-activated K (+)-channel genes and cardiovascular disease. , 2009 Dec 31 , ().
110. Pubmed Takacs Z. et al. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library. Proc. Natl. Acad. Sci. U.S.A., 2009 Dec 29 , 106 (22211-6).
109. Pubmed Levano S. et al. Increasing the number of diagnostic mutations in malignant hyperthermia. Hum. Mutat., 2009 Apr , 30 (590-8).
108. Pubmed Carpenter D. et al. The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med. Genet., 2009 , 10 (104).
107. Pubmed Sørensen M. et al. Aldosterone increases KCa1.1 (BK) channel-mediated colonic K+ secretion. J. Physiol. (Lond.), 2008 Sep 1 , 586 (4251-64).
106. Pubmed Ohrtman J. et al. Sequence differences in the IQ motifs of CaV1.1 and CaV1.2 strongly impact calmodulin binding and calcium-dependent inactivation. J. Biol. Chem., 2008 Oct 24 , 283 (29301-11).
105. Pubmed Struyk A. et al. Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis. J. Gen. Physiol., 2008 Oct , 132 (447-64).
104. Pubmed Chabrier S. et al. Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene. J. Med. Genet., 2008 Oct , 45 (686-8).
103. Pubmed Ozaki H. et al. Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis. Endocr. J., 2008 Mar , 55 (113-9).
102. Pubmed Nakamoto T. et al. Apical maxi-K (KCa1.1) channels mediate K+ secretion by the mouse submandibular exocrine gland. Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C810-9).
101. Pubmed Treves S. et al. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. , 2008 Jun , 8 (319-26).
100. Pubmed Meyer T. et al. Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation. Muscle Nerve, 2008 Jan , 37 (120-4).
99. Pubmed Tricarico D. et al. Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats. Neuromuscul. Disord., 2008 Jan , 18 (74-80).
98. Pubmed Matza D. et al. A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity, 2008 Jan , 28 (64-74).
97. Pubmed Stroffekova K. et al. Ca2+/CaM-dependent inactivation of the skeletal muscle L-type Ca2+ channel (Cav1.1). Pflugers Arch., 2008 Feb , 455 (873-84).
96. Pubmed Strube C. et al. Absence of regulation of the T-type calcium current by Cav1.1, beta1a and gamma1 dihydropyridine receptor subunits in skeletal muscle cells. Pflugers Arch., 2008 Feb , 455 (921-7).
95. Pubmed Fang X. et al. Cloning, sequencing and identification of single nucleotide polymorphisms of partial sequence on the porcine CACNA1S gene. Sci. China, C, Life Sci., 2008 Apr , 51 (317-25).
94. Pubmed Bentzen B. et al. The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels. Mol. Pharmacol., 2007 Oct , 72 (1033-44).
93. Pubmed Sandoval A. et al. gamma1-dependent down-regulation of recombinant voltage-gated Ca2+ channels. Cell. Mol. Neurobiol., 2007 Nov , 27 (901-8).
92. Pubmed Houinato D. et al. Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family. Neuromuscul. Disord., 2007 May , 17 (419-22).
91. Pubmed Matos J. et al. Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl- secretion. Acta Physiol (Oxf), 2007 Mar , 189 (251-8).
90. Pubmed Kuzmenkin A. et al. Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity. Pflugers Arch., 2007 Jun , 454 (495-505).
89. Pubmed Kuzmenkin A. et al. Gating of the HypoPP-1 mutations: II. Effects of a calcium-channel agonist BayK 8644. Pflugers Arch., 2007 Jul , 454 (605-14).
88. Pubmed Struyk A. et al. A Na+ channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore. J. Gen. Physiol., 2007 Jul , 130 (11-20).
87. Pubmed Tang N. et al. The alpha(1S) subunit of the L-type calcium channel is not a predisposition gene for thyrotoxic periodic paralysis. Clin. Endocrinol. (Oxf), 2007 Feb , 66 (229-34).
86. Pubmed Kim J. et al. The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. J. Korean Med. Sci., 2007 Dec , 22 (946-51).
85. Pubmed Winczewska-Wiktor A. et al. Myopathy as the first symptom of hypokalemic periodic paralysis--case report of a girl from a Polish family with CACNA1S (R1239G) mutation. Adv Med Sci, 2007 , 52 Suppl 1 (155-7).
84. Pubmed Carle T. et al. Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis. Biochem. Biophys. Res. Commun., 2006 Sep 22 , 348 (653-61).
83. Pubmed Deng X. et al. Properties of ion channels in rabbit mesenchymal stem cells from bone marrow. Biochem. Biophys. Res. Commun., 2006 Sep 15 , 348 (301-9).
82. Pubmed Kageyama K. et al. Gene analysis of the calcium channel 1 subunit and clinical studies for two patients with hypokalemic periodic paralysis. J. Endocrinol. Invest., 2006 Nov , 29 (928-33).
81. Pubmed Misonou H. et al. Immunolocalization of the Ca2+-activated K+ channel Slo1 in axons and nerve terminals of mammalian brain and cultured neurons. J. Comp. Neurol., 2006 May 20 , 496 (289-302).
80. Pubmed Anderson A. et al. The junctional SR protein JP-45 affects the functional expression of the voltage-dependent Ca2+ channel Cav1.1. J. Cell. Sci., 2006 May 15 , 119 (2145-55).
79. Pubmed Ke Q. et al. [The mutation R672H in SCN4A gene exists in Chinese patients with hypokalaemic periodic paralysis] Zhonghua Yi Xue Za Zhi, 2006 Mar 21 , 86 (724-7).
78. Pubmed Wu S. et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain, 2006 Jun , 129 (1470-80).
77. Pubmed Ke Q. et al. [R1239H mutation of CACNA1S gene in a Chinese family with hypokalaemic periodic paralysis] Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Jun , 23 (272-4).
76. Pubmed Ivanov A. et al. Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle. J. Physiol. (Lond.), 2006 Jan 1 , 570 (73-84).
75. Pubmed Venance S. et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain, 2006 Jan , 129 (8-17).
74. Pubmed Thompson J. et al. Membrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel. J. Gen. Physiol., 2006 Feb , 127 (159-69).
73. Pubmed Dranchak P. et al. Exclusion of linkage of the RYR1, CACNA1S, and ATP2A1 genes to recurrent exertional rhabdomyolysis in Thoroughbreds. Am. J. Vet. Res., 2006 Aug , 67 (1395-400).
72. Pubmed Fang X. et al. Mapping CACNA1S to chromosome 10 in swine using radiation hybrid mapping. Anim. Genet., 2005 Oct , 36 (437).
71. Pubmed Vicart S. et al. Human skeletal muscle sodium channelopathies. Neurol. Sci., 2005 Oct , 26 (194-202).
70. Pubmed Monnier N. et al. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum. Mutat., 2005 Nov , 26 (413-25).
69. Pubmed Wang Q. et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J. Mol. Med., 2005 Mar , 83 (203-8).
68. Pubmed Carbonneau L. et al. Multiple loops of the dihydropyridine receptor pore subunit are required for full-scale excitation-contraction coupling in skeletal muscle. Biophys. J., 2005 Jul , 89 (243-55).
67. Pubmed Altafaj X. et al. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor. J. Biol. Chem., 2005 Feb 11 , 280 (4013-6).
66. Pubmed Wang Y. et al. The solution structure of BmTx3B, a member of the scorpion toxin subfamily alpha-KTx 16. Proteins, 2005 Feb 1 , 58 (489-97).
65. Pubmed Lin S. et al. Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis. Am. J. Med. Sci., 2005 Feb , 329 (66-70).
64. Pubmed Kim J. et al. A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G). J. Korean Med. Sci., 2005 Feb , 20 (162-5).
63. Pubmed Hulme J. et al. Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of CaV1.1 channels in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A., 2005 Apr 5 , 102 (5274-9).
62. Pubmed Schalin-Jantti C. et al. Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis. Horm. Res., 2005 , 63 (139-44).
61. Pubmed Miller T. et al. Correlating phenotype and genotype in the periodic paralyses. Neurology, 2004 Nov 9 , 63 (1647-55).
60. Pubmed Dafi O. et al. Negatively charged residues in the N-terminal of the AID helix confer slow voltage dependent inactivation gating to CaV1.2. Biophys. J., 2004 Nov , 87 (3181-92).
59. Pubmed Kim M. et al. Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation. Neuromuscul. Disord., 2004 Nov , 14 (727-31).
58. Pubmed Links T. et al. [From gene to diseases; hypokalemic periodic paralysis] , 2004 May 22 , 148 (1035-8).
57. Pubmed Lunardi J. et al. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex] Rev. Neurol. (Paris), 2004 May , 160 (S70-7).
56. Pubmed Kawamura S. et al. A family of hypokalemic periodic paralysis with CACNA1S gene mutation showing incomplete penetrance in women. Intern. Med., 2004 Mar , 43 (218-22).
55. Pubmed Carrillo E. et al. Regulation of muscle Cav1.1 channels by long-term depolarization involves proteolysis of the alpha1s subunit. J. Membr. Biol., 2004 Jun 1 , 199 (155-61).
54. Pubmed Marchant C. et al. Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia. Muscle Nerve, 2004 Jul , 30 (114-7).
53. Pubmed Heimann P. et al. Elimination by necrosis, not apoptosis, of embryonic extraocular muscles in the muscular dysgenesis mutant of the mouse. Cell Tissue Res., 2004 Feb , 315 (243-7).
52. Pubmed Vicart S. et al. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology, 2004 Dec 14 , 63 (2120-7).
51. Pubmed Tricarico D. et al. Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats. FASEB J., 2004 Apr , 18 (760-1).
50. Pubmed Carsana A. et al. Identification of new polymorphisms in the CACNA1S gene. Clin. Chem. Lab. Med., 2003 Jan , 41 (20-2).
49. Pubmed Muniz V. et al. Screening for mutations in the RYR1 gene in families with malignant hyperthermia. J. Mol. Neurosci., 2003 , 21 (35-42).
48. Pubmed Monnier N. et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology, 2002 Nov , 97 (1067-74).
47. Pubmed Dias Da Silva M. et al. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. Clin. Endocrinol. (Oxf), 2002 Mar , 56 (367-75).
46. Pubmed Lehmann-Horn F. et al. Periodic paralysis: understanding channelopathies. , 2002 Jan , 2 (61-9).
45. Pubmed Lucet V. et al. [Andersen syndrome, ventricular arrhythmias and channelopathy (a case report)] , 2002 Dec , 9 (1256-9).
44. Pubmed Kuzmenkin A. et al. Enhanced inactivation and pH sensitivity of Na(+) channel mutations causing hypokalaemic periodic paralysis type II. Brain, 2002 Apr , 125 (835-43).
43. Pubmed Brooks C. et al. No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia population. , 2002 Apr , 88 (587-9).
42. Pubmed Davies N. et al. Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK. Neurology, 2001 Oct 9 , 57 (1323-5).
41. Pubmed Ikeda Y. et al. [Familial hypokalemic periodic paralysis] , 2001 Nov , 11 (1464-7).
40. Pubmed Kim S. et al. Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis. Nephrol. Dial. Transplant., 2001 May , 16 (939-44).
39. Pubmed Stewart S. et al. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin. Genet., 2001 Mar , 59 (178-84).
38. Pubmed Sternberg D. et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain, 2001 Jun , 124 (1091-9).
37. Pubmed Katsuno M. et al. [A case of familial hypokalemic periodic paralysis with hyperuricemia during paralytic attack and genetic analysis of the pedigree] Rinsho Shinkeigaku, 2001 Jul , 41 (397-401).
36. Pubmed Tricarico D. et al. Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann. Neurol., 2000 Sep , 48 (304-12).
35. Pubmed Domínguez-Morán J. et al. Clinical-molecular study of a family with essential tremor, late onset seizures and periodic paralysis. , 2000 Oct , 9 (493-7).
34. Pubmed Wada T. et al. Hypokalemic periodic paralysis and mutations in the CACNL1A3 gene: case study in a Japanese family. Pediatr Int, 2000 Jun , 42 (325-7).
33. Pubmed Struyk A. et al. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation. J. Neurosci., 2000 Dec 1 , 20 (8610-7).
32. Pubmed Jurkat-Rott K. et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc. Natl. Acad. Sci. U.S.A., 2000 Aug 15 , 97 (9549-54).
31. Pubmed Vainzof M. et al. Does the A3333G mutation in the CACNL1A3 gene, detected in malignant hyperthermia, also occur in central core disease? Genet. Test., 2000 , 4 (383-6).
30. Pubmed Ruff R. et al. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology, 1999 Oct 22 , 53 (1556-63).
29. Pubmed Bulman D. et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology, 1999 Dec 10 , 53 (1932-6).
28. Pubmed Morrill J. et al. Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H. J. Neurosci., 1998 Dec 15 , 18 (10320-34).
27. Pubmed Lory P. et al. [Physiopathology of calcium channels: identification of calcium channelopathies] C. R. Seances Soc. Biol. Fil., 1998 , 192 (137-47).
26. Pubmed Sillén A. et al. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am. J. Med. Genet., 1997 Mar 3 , 69 (102-6).
25. Pubmed Robinson R. et al. A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees. Hum. Mol. Genet., 1997 Jun , 6 (953-61).
24. Pubmed Lapie P. et al. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul. Disord., 1997 Jun , 7 (234-40).
23. Pubmed Monnier N. et al. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet., 1997 Jun , 60 (1316-25).
22. Pubmed Fouad G. et al. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul. Disord., 1997 Jan , 7 (33-8).
21. Pubmed Ikeda Y. et al. [Mutation analysis of the CACNL1A3 gene in Japanese hypokalemic periodic paralysis families] Nippon Rinsho, 1997 Dec , 55 (3247-52).
20. Pubmed Lapie P. et al. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. FEBS Lett., 1996 Mar 18 , 382 (244-8).
19. Pubmed Lerche H. et al. Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis. Pflugers Arch., 1996 Jan , 431 (461-3).
18. Pubmed Grosson C. et al. Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul. Disord., 1996 Jan , 6 (27-31).
17. Pubmed Hogan K. et al. The structure of the gene encoding the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics, 1996 Feb 1 , 31 (392-4).
16. Pubmed Sipos I. et al. Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes. J. Physiol. (Lond.), 1995 Mar 1 , 483 ( Pt 2) (299-306).
15. Pubmed Iaizzo P. et al. Differential diagnosis of periodic paralysis aided by in vitro myography. Neuromuscul. Disord., 1995 Mar , 5 (115-24).
14. Pubmed Boerman R. et al. Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis. J. Med. Genet., 1995 Jan , 32 (44-7).
13. Pubmed Elbaz A. et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am. J. Hum. Genet., 1995 Feb , 56 (374-80).
12. Pubmed Lehmann-Horn F. et al. Altered calcium currents in human hypokalemic periodic paralysis myotubes expressing mutant L-type calcium channels. Soc. Gen. Physiol. Ser., 1995 , 50 (101-13).
11. Pubmed Plassart E. et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP). Hum. Genet., 1994 Nov , 94 (551-6).
10. Pubmed Fontaine B. et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat. Genet., 1994 Mar , 6 (267-72).
9. Pubmed Iles D. et al. Refined localization of the alpha 1-subunit of the skeletal muscle L-type voltage-dependent calcium channel (CACNL1A3) to human chromosome 1q32 by in situ hybridization. Genomics, 1994 Feb , 19 (561-3).
8. Pubmed Hogan K. et al. Cloning of the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics, 1994 Dec , 24 (608-9).
7. Pubmed Sansone V. et al. Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family. , 1994 Dec , 15 (473-80).
6. Pubmed Jurkat-Rott K. et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet., 1994 Aug , 3 (1415-9).
5. Pubmed Drouet B. et al. The gene coding for the alpha 1 subunit of the skeletal dihydropyridine receptor (Cchl1a3 = mdg) maps to mouse chromosome 1 and human 1q32. Mamm. Genome, 1993 Sep , 4 (499-503).
4. Pubmed Sudbrak R. et al. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect. Hum. Mol. Genet., 1993 Jul , 2 (857-62).
3. Pubmed Gregg R. et al. Assignment of the human gene for the alpha 1 subunit of the skeletal muscle DHP-sensitive Ca2+ channel (CACNL1A3) to chromosome 1q31-q32. Genomics, 1993 Jan , 15 (107-12).
2. Pubmed Casley W. et al. Exclusion of linkage between hypokalemic periodic paralysis (HOKPP) and three candidate loci. Genomics, 1992 Oct , 14 (493-4).
1. Pubmed Chin H. et al. The gene for the alpha 1 subunit of the skeletal muscle dihydropyridine-sensitive calcium channel (Cchl1a3) maps to mouse chromosome 1. Genomics, 1992 Dec , 14 (1089-91).